Gender-sensitive association of CFTR gene mutations and 5T allele emerging from a large survey on infertility

Molecular Human Reproduction

Volumn 11, Issue 8, 2005, Pages 607-614

  Morea, Antonella ^a   Cameran, Marilena ^a   Rebuffi, Anna Grazia ^a   Marzenta, Diana ^a   Marangon, Oriana ^a   Picci, Luigi ^a   Zacchello, Franco ^a   Scarpa, Maurizio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

CFTR; Infertility; IVS8 T; IVS8 TG

Indexed keywords

DNA; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DENATURING GRADIENT GEL ELECTROPHORESIS; DNA SEQUENCE; DOT HYBRIDIZATION; FEMALE; FEMALE INFERTILITY; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HEALTH SURVEY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MALE INFERTILITY; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REPRODUCTION; SENSITIVITY ANALYSIS; SEQUENCE ANALYSIS; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

ALLELES; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INFERTILITY, FEMALE; INFERTILITY, MALE; MALE; MUTATION; POLYMORPHISM, GENETIC; RNA SPLICE SITES; SEX CHARACTERISTICS;

EID: 27144556952     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gah214     Document Type: Article

References (47)

1. Accurso FJ and Sontag MK (2003) Seeking modifier genes in cystic fibrosis. Am J Respir Crit Care Med 167,289-290.
2. Acton JD and Wilmott RW (2001) Phenotype of CF and the effects of possible modifier genes. Paediatr Respir Rev 2,332-339.
3. Bobadilla JL, Macek M Jr, Fine JP and Farrell PM (2002) Cystic fibrosis: a worldwide analysis of CFTR mutations-correlation with incidence data and application to screening. Hum Mutat 19,575-606.
4. Bonizzato A, Bisceglia L, Marigo C, Nicolis E, Bombieri C, Castellani C, Borgo G, Zelante L, Mastella G, Cabrini G et al. (1995) Analysis of the complete coding region of the CFTR gene in a cohort of CF patients from North East Italy: Identification of 90% of the mutations. Hum Genet 95,397-402.
5. Chehab FF and Wall J (1992) Detection of multiple cystic fibrosis mutations by reverse dot blot hybridization: A technology for carrier screening. Hum Genet 89,163-168.
6. Chillon M, Casals T, Mercier B, Bassas L, Lissens W, Silber S, Romey M-C, Ruiz-Romero J, Verlingue C, Claustres M et al. (1995) Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N Engl J Med 332,1475-1480.
7. Chu CS, Trapnell BC, Curristin SM, Cutting GR and Crystal RG (1993) Genetic basis of variable exon skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nat Genet 3,151-156.
8. Claustres M, Guittard C, Bozon D, Chevalier F, Verlingue C, Ferec C, Girodon E, Cazeneuve C, Bienvenu T, Lalau G et al. (2000) Spectrum of CFTR mutations in cystic fibrosis and in congenital absence of the vas deferens in France. Hum Mutat 16,143-156.
9. Costes B, Fanen P, Goossens M and Ghanem (1993) A rapid, efficient, and sensitive assay for simultaneous detection of multiple cystic fibrosis mutations. Hum Mutat 2,185-191.
10. Cuppens H, Lin W, Jaspers M, Costes B, Teng H, Vankeerberghen A, Jorissen M, Droogmans G, Reynaert I, Goossens M et al. (1998) Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (TG)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation. J Clin Invest 101,487-496.
11. Cystic Fibrosis Genetic Analysis Consortium (2005) Available from http://www.genet.sickkids.on.ca/cftr/
12. Demko CA, Byard PJ and Davis PB (1995) Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection. J Clin Epidemiol 48,1041-1049.
13. de Meeus A, Guittard C, Desgeorges M, Carles S, Demaille J and Claustres M (1998) Linkage disequilibrium between the M470V variant and the IVS8 polyT alleles of the CFTR gene in CBAVD. J Med Genet 35,594-596.
14. Dörk T, Neumann T, Wulbrand U, Wulf B, Kälin N, Maaß G, Krawczak M, Guillermit H, Ferec C and Horn G (1992) Intra- and extragenic marker haplotypes of CFTR mutations in cystic fibrosis families. Hum Genet 88,417-425.
15. Dörk T, Dworniczak B, Aulehla-Sholz C, Wieczorek D, Bohm I, Mayerova A, Seydewitz HH, Nieschlag E, Meschede D, Horst J et al. (1997) Distinct spectrum of CFTR gene mutations in congenital absence of vas deferens. Hum Genet 100,365-377.
16. Fogarty A, Hubbard R and Britton J (2000) International comparison of median age at death from cystic fibrosis. Chest 117,1656-1660.
17. Foresta C, Ferlin A, Gianaroli L and Dallapiccola B (2002) Guidelines for the appropriate use of genetic tests in infertile couples. Eur J Hum Genet 10,303-312.
18. Grasemann H, Michler E, Wallot M and Ratjen F (1997) Decreased concentration of exhaled nitric oxide (NO) in patients with cystic fibrosis. Pediatr Pulmonol 24,173-177.
19. Grasemann H, van's Gravesande KS, Büsher R, Drazen JM and Ratjen F (2003) Effects of sex and of gene variants in constitutive nitric oxide synthases on exhaled nitric oxide. Am J Respir Crit Care Med 167,1113-1116.
20. Groman JD, Hefferon TW, Casals T, Bassas L, Estivill X, Des Georges M, Guittard C, Koudova M, Fallin MD, Nemeth K et al. (2004) Variation in a repeat sequence determines whether a common variant of the cystic fibrosis transmembrane conductance regulator gene is pathogenic or benign. Am J Hum Genet 74,176-179.
21. Healy DL, Trounson AO and Andersen AN (1994) Female infertility: Causes and treatment. Lancet 343,1539-1544.
22. Jarvi K, Zielenski J, Wilschanski M, Durie P, Buckspan M, Tullis E, Markiewicz D and Tsui L-C (1995) Cystic fibrosis transmembrane conductance regulator and obstructive azoospermia. Lancet 345,1578.
23. Jecquier AM, Ansell ID and Bullimore NJ (1985) Congenital absence of the vasa deferentia presenting with infertility. J Androl 6,15-19.
24. Kerem E, Reisman J, Corey M, Canny GJ and Levison H (1992) Prediction of mortality in patients with cystic fibrosis. N Engl J Med 326,1187-1191.
25. Kopito LE, Kosasky HJ and Shwachman H (1973) Water and electrolytes in cervical mucus from patients with cystic fibrosis. Fertil Steril 24,512-516.
26. Küpker W, Schwinger E, Hiort O, Ludwig M, Nikolettos N and Schlegel Diedrich K (1999) Genetic of male infertility: Consequences for the clinical workup. Hum Reprod 14,24-37.
27. Lewis-Jones DI, Gazvani MR and Mountford R (2000) Cystic fibrosis in infertility: Screening before assiOted reproduction: opinion. Hum Reprod 15,2415-2417.
28. Macek M Jr, Macek M Sr, Krebsova A, Nash E, Hamosh A, Reis A, Varon-Mateeva R, Schmidtke J, Maestri NE, Sperling K et al. (1997) Possible association of the allele status of the CS.7/HhaI polymorphysm 5′ of the CFTR gene with postnatal female survival. Hum Genet 99,565-572.
29. Mak V and Jarvi KA (1996) The genetics of male infertility. J Urol 156,1245-1257.
30. Meschede D, Dworniczak B, Behre HM, Kliesch S, Claustres M, Nieschlag E and Horst J (1997) CFTR gene mutations in men with bilateral ejaculatory-duct obstruction and anomalies of the seminal vescicles. Am J Hum Genet 61,1200-1202.
31. Mickle J, Milunsky A, Amos JA and Oates RD (1995) Congenital unilateral absence of the vas deferens: A heterogeneous disorder with two distinct sub-populations based upon aetiology and mutational status of the cystic fibrosis gene. Hum Reprod 10, 1728-1735.
32. Niksic M, Romano M, Buratti E, Pagani F and Baralle FE (1999) Functional analysis of cis-acting elements regulating the alternative splicing of human CFTR exon 9. Hum Mol Genet 8,2339-2349.
33. Noone PG, Pue CA, Zhou Z, Friedman KJ, Wakeling EL, Ganeshanathan M, Simon RH, Silverman LM and Knowles MR (2000) Lung disease associated with the IVS8 5T allele of the CFTR gene. Am J Respir Crit Care Med 162,1919-1924.
34. O'Connor GT, Quinton HB, Kahn R, Robichaud P, Maddock J, Lever T, Detzer M and Brooks JG (2002) Case-mix adjustment for evaluation of mortality in cystic fibrosis. Pediatr Pulmonol 33,99-105.
35. Okada H, Yoshimura, K, Fujioka H, Tatsumi N, Gotoh A, Fujisawa M, Gohji K, Arakawa S, Kato H, Kobayashi S-I et al. (1999) Assisted reproduction technology for patients with congenital bilateral absence of vas deferens. J Urol 161,1157-1162.
36. Rendine S, Calafell F, Cappello N, Gagliardini R, Caramia G, Rigillo N and Silvetti M (1997) Genetic history of cystic fibrosis mutations in Italy. I. Regional distribution. Ann Hum Genet 61,411-424.
37. Riordan JR, Rommens JM, Kerem B-S, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou J-L et al. (1989) Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science 245,1066-1072.
38. Rosenfeld M, Davis R, FitzSimmons S, Pepe M and Ramsey B (1997) Gender gap in cystic fibrosis mortality. Am J Epidemiol 145,794-803.
39. Shawker RH, Hubbard VS, Reichert CM and Guerreiro De Matox OM (1983) Cystic ovaries in cystic fibrosis: An ultrasound and autopsy study. J Ultrasound Med 2,439-444.
40. Sokol RZ (2001) Infertility in men with cystic fibrosis. Curr Opin Pulm Med 7,421-426.
41. Stallings VA (2003) Gender, death and cystic fibrosis: Is energy expenditure a component? J Pediatr 142,4-146.
42. tead RJ, Hodson ME, Batten JC, Adams J and Jacobs HS (1987) Amenorrhoea in cystic fibrosis. Clin Endocrinol (Oxf) 26,187-195.
43. Tsang KW, Ip SK, Leung R, Tipoe GL, Chan SL, Shum IH, Ip MS, Yan C, Fung PC, Chan-Yeung M et al. (2001) Exhaled nitric oxide: The effects of age, gender and body size. Lung 179,83-91.
44. Wall J, Shiping C and Chehab FF (1995) A 31 mutation assay for cystic fibrosis testing in the clinical molecular diagnostics laboratory. Hum Mutat 5,333-338.
45. Welsh MJ, Tsui L-C, Boat TF and Beaudet AL (1995) Cystic fibrosis. In Scriver CR, Beaudet AL, Sly WS and Valle D (eds), The Metabolic and Molecular Bases of Inherited Disease. McGraw-Hill, New York, pp. 3799-3876.
46. Zielenski J, Rozmahel R, Bozon D, Kerem B-S, Grzelczak Z, Riordan JR, Rommens J and Tsui L-C (1991) Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics 10,214-228.
47. Zielenski J, Patrizio P, Corey M, Handelin B, Markiewicz D, Asch R and Tsui L-C (1995) CFTR gene variant for patients with congenital absence of vas deferens. Am J Hum Genet 57,958-960.